Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance 2023-09-18 07:57
The "Jiangsu-Germany Dialogue 2023" Held in Changzhou 2023-09-15 16:38
Cure Genetics and Frametact Reach a $60 Million Collaboration and Licensing Agreement for the Development of Gene Therapy for Familial Neurological Diseases 2023-09-14 23:00
Dizal Announces China CDE Acceptance of New Drug Application for Golidocitinib for Relapsed or Refractory PTCL 2023-09-14 17:07
Asieris' New Drug APL-1401 Completes First Administration in Patient with Moderately to Severely Active UC 2023-09-14 16:54
Nona Biosciences Expands Antibody Discovery Collaboration with BeiGene 2023-09-14 16:00
Asieris Announces Positive Interim Analysis Results in Phase II Clinical Trial of Oral APL-1202 in Combination with Tislelizumab, a PD-1 inhibitor, as Neoadjuvant Therapy for Muscle Invasive Bladder Cancer 2023-09-13 19:09
Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling 2023-09-13 17:51
J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI 2023-09-13 15:58
Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China 2023-09-13 14:24
Caliway Announces CBL-514 Phase 2 Study Topline Results for Dercum's Disease, Showing 64.5% of Lipomas with Complete Clearance or Dimensions Reduction of Over 50% and Reduced Pain by 4.7 2023-09-13 13:42
GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. 2023-09-13 00:00
Standigm's "Green Ribbon Campaign" to support Mitochondria Disease Awareness Week 2023-09-12 21:00
Henlius Expands Collaboration with KGbio to Develop, Commercialize and Supply Henlius' novel anti-PD-1 mAb HANSIZHUANG in MENA 2023-09-12 19:24
Mabwell and WuXi XDC Sign Long-Term ADC Strategic Collaboration to Accelerate Global Layout of Innovative Biologics 2023-09-08 15:30
World Orphan Drug Alliance Welcomes Specialised Therapeutics 2023-09-08 04:00
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting 2023-09-06 20:00
Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer 2023-09-06 19:00
CANbridge to Participate in Two Investor Conferences in September 2023-09-06 16:06
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile 2023-09-05 20:00
1 40 41 42 43 44 222